81443 Genetic testing

CPT 81443

CPT 81443: Expanded Carrier Screening PanelExpanded Carrier Screening Panel

The short answer

81443 is the panel code for expanded carrier screening: a single sequencing analysis of fifteen or more genes tied to inherited conditions such as cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies. The performing lab bills it. Coverage is far less settled than for NIPT, because many payers cover a handful of individually coded gene tests while treating the expanded panel as investigational.

Source: ACOGSource: CMS

When to use 81443

81443 applies when the lab sequences a broad carrier panel of at least fifteen genes in one run. The alternative coding path is a stack of single-gene codes (cystic fibrosis, SMA, fragile X, hemoglobin variants each have their own). Which path the lab takes is a lab decision, but it has real consequences for the patient's bill: payers that cover guideline-backed single-gene tests may still deny the panel code outright. The practice can steer the outcome by matching the order to what the payer covers, or by having the cost conversation before the draw.

Panel code vs single-gene codes

81443 · Expanded panel

One code, one claim line, 15 or more genes
One draw covers conditions across ancestries
Coverage varies widely; many plans call it investigational
Often the larger patient balance when denied

Single-gene codes

Separate code per gene (CF, SMA, fragile X, hemoglobinopathies)
Aligns with the conditions ACOG says to offer every patient
Best coverage track record across payers
Total billed charges can stack up across lines

Documentation checklist

Because coverage is uneven, the record needs to support both the medical rationale and the patient-cost conversation.

✓ Order specifying panel vs targeted testing, with the clinical reason

✓ Family history or ethnicity-based risk factors when they exist (they strengthen appeals)

✓ Pre-test counseling documented: carrier screening is optional, results affect reproductive decisions

✓ Verification of the payer's carrier-screening policy tier before the draw

✓ Patient cost estimate or ABN when the panel code is likely to deny

✓ Partner testing rationale documented separately if the partner is screened

Global package rules

Carrier screening is a lab service outside the global OB package; it never interacts with the 59400 claim, and ideally it happens before pregnancy anyway. It is priced on the Clinical Laboratory Fee Schedule, not the Medicare Physician Fee Schedule, so there is no MPFS fee table on this page. The economics worth knowing: ACOG guidance supports offering carrier screening (at minimum cystic fibrosis and spinal muscular atrophy) to every pregnant patient, and payers cover those single-gene tests reliably. The expanded panel is where policies diverge into tiers: some plans cover 81443 like any other screen, some cover it only with family history or specific risk factors, and some exclude panels entirely while paying the component single-gene codes. The lab's code choice, panel code vs individual codes, is often the difference between a covered claim and a large patient balance for the identical tubes of blood. ACOG

Common denials

CO-50 Panel deemed investigational or not medically necessary

Why it happens

The plan covers targeted carrier tests but classifies expanded panels as experimental, or requires risk factors the claim did not show.

How to fix

Appeal with any documented family history or risk factors. If the plan's exclusion is categorical, the practical fix is prospective: order the covered single-gene tests for that payer's patients, or set the self-pay expectation before the draw.

Source: ACOG

CO-197 Prior authorization missing

Why it happens

Plans that do cover 81443 frequently gate it behind precertification, sometimes with genetic-counseling prerequisites.

How to fix

Check the auth requirement during eligibility verification, and complete any required counseling step first. Request retro authorization where the payer allows it.

Source: CMS

CO-96 Non-covered benefit

Why it happens

Some plans exclude expanded carrier screening as a benefit category regardless of necessity, especially for partner (non-member) testing.

How to fix

Confirm the exclusion, then apply the pre-draw cost agreement. Most labs offer capped self-pay pricing for panels; route the patient there rather than to a full billed-charge balance.

Source: CMS

CO-16 Claim missing required information

Why it happens

Molecular claims commonly reject for a missing test-registry identifier or an unspecific diagnosis code.

How to fix

The lab resubmits with the registry Z-identifier where required. On the ordering side, use a specific carrier-screening or family-history diagnosis code rather than a bare encounter code.

Source: CMS

FAQ

What is the CPT code description for 81443?

In plain language, 81443 covers one laboratory analysis that sequences at least fifteen genes associated with inheritable conditions, screening a prospective or current parent for carrier status across many disorders at once.

Who bills 81443, the practice or the lab?

The performing laboratory. The practice bills only its own services, such as the draw or a distinct counseling visit. The practice's order and diagnosis code still shape whether the lab's claim pays.

Why did insurance pay for cystic fibrosis screening but deny the panel?

Because they are different codes with different policy status. Single-gene tests for guideline-recommended conditions have long-standing coverage; the expanded panel code is still labeled investigational by some plans. Same blood, different code, different outcome.

Is partner carrier screening covered?

Often not by the pregnant patient's plan, since the partner is a separate member (or not a member at all). Sequential screening, testing the patient first and the partner only for genes where the patient is a carrier, is the coverage-friendly pattern.

When is the best time to order carrier screening?

Preconception is the clinical ideal and changes nothing about coding. In practice most screening happens at the first prenatal visit; it remains a separately billed lab service either way, never part of the global package.

Does 81443 need prior authorization?

Frequently, yes, and some payers also require genetic counseling before approval. Build the auth check into the ordering workflow, because a retro auth after a denial is harder to win.

CPT® is a registered trademark of the American Medical Association. Educational reference only, not billing, legal, or medical advice. Maintained by Ouma Health, a maternal-fetal telemedicine practice. Printed from obcodingguide.com, content current as of July 2026.